Linda Burghardt, PhD, a researcher in Great Neck, New York, started taking semaglutide because her doctor thought it might ...

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...

Now the arrival of a Wegovy pill in U.S. pharmacies feels like a line in the sand between the first and second era of ...

As Indiana enters 2026, a major shift in the healthcare landscape is promising to make high-demand weight-loss medications more accessible to millions. With ...

Danish pharmaceutical giant Novo Nordisk has officially launched its once-daily Wegovy weight-loss pill in the United States, ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

Starting next week, Danish company Novo Nordisk is launching its Wegovy weight loss pill in the US. Consumers can purchase ...

Novo’s oral Wegovy launch has intensified competition for Eli Lilly heading into 2026. ・Lilly’s outlook hinges on oral drug ...

Food-insecure individuals have fewer total annual visits (in-person and via telehealth) across 4 types of office-based and outpatient visits: general checkup, diagnosis or treatment, psychotherapy or ...

Governor Greg Gianforte and Montana Department of Public Health and Human Services (DPHHS) Director Charlie Brereton have announced a historic $233 million investment from the Trump administration to ...

Danish drug manufacturer Novo Nordisk has launched its once-daily Wegovy weight-loss pill in the United States.